REGENXBIO Inc. (RGNX)
1 Item 5.02 filing since 2026-10-16 · 1 with an open seat · roles: Director. Nasdaq. Biological Products, (No Diagnostic Substances). State: MD.
| Score | Filed | Event | Role | Person | Seat | Summary |
|---|---|---|---|---|---|---|
| 50 | 2026-10-16 | Departure | Director | subscribers | Open | REGENXBIO Inc. (RGNX): director Daniel Tassé reason not stated |
Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works